A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal Cancer

NCT02453464 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Sevacizumab
DRUG: Irinotecan
DRUG: 5-FU
DRUG: Leucovorin

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.